If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email email@example.com.
Please tell us what format you need. It will help us if you say what assistive technology you use.
Invitation to attend the Open Meeting of the Veterinary Medicines Directorate
Suspension of Velactis following adverse events in dairy cattle
Proposed changes to publishing Licensing information in MAVIS
Top ten Imported Veterinary Medicines Quarterly Report from 1 April – 30 June 2016
Summary: Company Visit Questionnaires 1 April 2015 to 31 March 2016